作　　者： (于普丽）;

机构地区： 山东省东明县妇幼保健院,274500

出　　处： 《中国社区医师》 2017年第25期67-68,共2页

摘　　要： 目的:探讨经鼻持续气道正压通气联合肺表面活性物质治疗早产儿呼吸窘迫综合征的效果。方法:收治呼吸窘迫综合征早产儿81例,根据入院顺序随机分为对照组40例和观察组41例。对照组给予肺表面活性物质治疗,观察组给予经鼻持续气道正压通气联合肺表面活性物质治疗。结果:观察组治疗后各项肺功能指标均明显优于对照组(P<0.05);观察组住院时间、并发症发生率均明显优于对照组(P<0.05)。结论:经鼻持续气道正压通气联合肺表面活性物质治疗早产儿呼吸窘迫综合征的临床效果突出。 Objective:To investigate the effect of nasal continuous positive airway pressure ventilation combined with pulmonary surfactant treatment in premature infants with respiratory distress syndrome.Methods:81premature infants with respiratory distress syndrome were selected.According to the order of admission,they were randomly divided into the control group with40cases and the observation group with41cases.The control group were treated with pulmonary surfactant therapy,and the observation group was given nasal continuous positive pressure ventilation combined with pulmonary surfactant therapy.Results:The pulmonary function indexes of the observation group were obviously better than that of the control group(P<0.05);the time of hospitalization and the complication rate of the observation group were better than those of the control group(P<0.05).Conclusion:The clinical effect of nasal continuous positive airway pressure combined with pulmonary surfactant treatment in premature infants with respiratory distress syndrome is obvious.

关 键 词： 经鼻持续气道正压通气 肺表面活性物质 早产儿 呼吸窘迫综合征